DESIGN OF A PHASE 3 CLINICAL TRIAL IN DIABETIC NEPHROPATHY (DN) WITH PYRIDORIN

被引：0
|
作者：
Dwyer, J. P. [1 ]
Umanath, K. [2 ]
Fox, J. W. [3 ]
Peterson, R. [3 ]
Broome, B. R. [1 ]
Sika, M. [1 ]
Lewis, J. B. [1 ]
机构：
[1] Vanderbilt Univ, Nashville, TN 37235 USA
[2] Henry Ford Hosp, Detroit, MI 48202 USA
[3] NephroGenex Inc, Res Triangle Pk, NC USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2015年 / 65卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
71
引用
收藏
页码：A32 / A32
页数：1
相关论文
共 50 条
  • [1] Pyridorin in Type 2 Diabetic Nephropathy
    Lewis, Edmund J.
    Greene, Tom
    Spitalewiz, Samuel
    Blumenthal, Samuel
    Berl, Tomas
    Hunsicker, Lawrence G.
    Pohl, Marc A.
    Rohde, Richard D.
    Raz, Itamar
    Yerushalmy, Yair
    Yagil, Yoram
    Herskovits, Tommy
    Atkins, Robert C.
    Reutens, Anne T.
    Packham, David K.
    Lewis, Julia B.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (01): : 131 - 136
  • [2] A phase 2 clinical trial of pyridoxamine (Pyridorin™) in type 1 and type 2 diabetic patients with overt nephropathy (PYR-206)
    Williams, ME
    Bolton, WK
    Degenhardt, TP
    Schotzinger, R
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 7A - 7A
  • [3] Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy
    Heerspink, Hiddo J. L.
    Andress, Dennis L.
    Bakris, George
    Brennan, John J.
    Correa-Rotter, Ricardo
    Dey, Jyotirmoy
    Hou, Fan Fan
    Kitzman, Dalane W.
    Kohan, Donald
    Makino, Hirofumi
    McMurray, John
    Perkovic, Vlado
    Tobe, Sheldon
    Wigderson, Melissa
    Parving, Hans-Henrik
    de Zeeuw, Dick
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (06): : 1369 - 1376
  • [4] NephroGenex licenses pyridorin for diabetic nephropathy and acute renal failure
    不详
    [J]. DIALYSIS & TRANSPLANTATION, 2006, 35 (09) : 550 - 550
  • [5] FISHOIL IN DIABETIC NEPHROPATHY (DN)
    ROSSING, P
    HANSEN, BV
    NIELSEN, FS
    MYRUP, B
    PARVING, HH
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 383 - 383
  • [6] Human pharmacokinetics and metabolism of oral Pyridorin™, a novel therapeutic for diabetic nephropathy
    Degenhardt, TP
    Khalifah, RG
    Schotzinger, RJ
    [J]. DIABETOLOGIA, 2002, 45 : A366 - A366
  • [7] A phase 2 clinical investigation of pyridoxamine (Pyridorin™) in type 1 and type 2 diabetic patients with overt diabetic nephropathy (PYR-205/207)
    McGill, JB
    Degenhardt, TP
    Szabo, JR
    Khalifah, RG
    Schotzinger, RJ
    [J]. DIABETES, 2004, 53 : A138 - A138
  • [8] POLYMORPHISMS AT THE 3' REGION OF INSULIN GENE AND DIABETIC NEPHROPATHY (DN)
    FREIRE, MB
    DORIA, A
    LEE, J
    KROLEWSKI, AS
    [J]. DIABETES, 1995, 44 : A179 - A179
  • [9] SHORT STATURE AND DIABETIC NEPHROPATHY (DN)
    PARVING, HH
    ROSSING, P
    TARNOW, L
    NIELSEN, FS
    BOELSKIFTE, S
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 381 - 381
  • [10] A clinical trial in type 2 diabetic nephropathy
    Lewis, EJ
    Hunsicker, LG
    Rodby, RA
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S191 - S194
12345